Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03605108 · ClinicalTrials.gov registry record · NA

The Influence of Oral Probiotics on the Microbiome and Lipidome

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT03605108 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03605108, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to measure oil production of the face, facial properties, and gut bacteria in people being given oral probiotics. Probiotic supplements contain active cultures of bacteria that are thought to be beneficial to human health.The investigators want to find out if probiotics taken by mouth alter the bacteria in subject's gut and subject's skin oil production compared to a placebo. This is a single blind study and subject may receive a probiotic or a placebo for the first half of the study and a placebo or a probiotic for the second half of the study. Subject will not know what was given to participants.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Probiotic

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-06-29
Est. Completion 2019-05-09
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03605108

The ClinicalTrials.gov registry entry for NCT03605108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03605108 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03605108 about?

NCT03605108 is a clinical study titled "The Influence of Oral Probiotics on the Microbiome and Lipidome". The purpose of this study is to measure oil production of the face, facial properties, and gut bacteria in people being given oral probiotics. Probiotic supplements contain active cultures of bacteria that are thought to be beneficial to human health.The investigators want to find out if probiotics ...

What is the current status of trial NCT03605108?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-06-29. Estimated completion is 2019-05-09.

What interventions are being tested in trial NCT03605108?

The interventions under investigation include: Placebo (OTHER), Probiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03605108?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.